My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 5 results for

GO
Search Filters: Last 180 Days cancel Colorado cancel Population Health and Prevention cancel Social and Behavioral Health cancel

How States Can Leverage JUUL Settlement Funds to Promote Public Health

Health Policy Update,
Tobacco Control,
Funding,
Federal Government Affairs,
State Health Policy,
Territorial Health Policy,
Arizona,
California,
Colorado,
Connecticut,
Illinois,
Indiana,
Iowa,
Massachusetts,
Minnesota,
Mississippi,
New Mexico,
New York,
North Carolina,
Pennsylvania,
Puerto Rico,
Washington, D.C.,
Amy Ciarlo,
Matta Sannoh

To address the youth tobacco epidemic, jurisdictions filed lawsuits against JUUL to end their marketing practices aimed at youth and to obtain compensation from the financial toll experienced by ...

Policies Supporting Young Families Can Reduce Adverse Childhood Experiences

Health Policy Update,
ACEs,
Infant and Child Health,
Women, Infant, Family Health Mental Health,
Elimination of Disparities,
State Health Policy,
Injury and Violence Prevention,
Colorado,
Delaware,
Georgia,
Hawaii,
Idaho,
Maine,
Minnesota,
Oregon,
Texas,
Utah,
Vermont,
Jessica Bissett

During the 2023 legislative session, a number of states enacted policies that advance ACEs prevention measures and support families in ensuring safe places for their children to live, grow, and play.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

State Health Policy,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, ...